Molecule
Tabelecleucel
- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Tabelecleucel is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- Yes
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Biologic
- Yes
- Identifiers
- UNII G3NJ7M8N4HQ114749444
All presentations
No presentations of Tabelecleucel are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Tabelecleucel available for export from India?
No presentation of Tabelecleucel is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Tabelecleucel authorised in the European Union?
Yes. Tabelecleucel has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Tabelecleucel need cold chain shipping?
No listed presentation of Tabelecleucel is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
References
- Ebvallo: European public assessment report (EPAR). European Medicines Agency. Retrieved 2 October 2026
Request Tabelecleucel for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.